Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Myocardial Disease
Antioxidant, EUK-8, Prevents Murine Dilated Cardiomyopathy
Satoru KawakamiAkina MatsudaTadahiro SunagawaYoshihiro NodaTakao KanekoShoichi TaharaYoshimi HiraumiSouichi AdachiHiromitsu MatsuiKatsuyuki AndoToshiro FujitaNaoki MaruyamaTakuji ShirasawaTakahiko Shimizu
著者情報
ジャーナル フリー

2009 年 73 巻 11 号 p. 2125-2134

詳細
抄録

Background: Mice lacking manganese-superoxide dismutase (Mn-SOD) activity exhibit the typical pathology of dilated cardiomyopathy (DCM). In the present study, presymptomatic and symptomatic mutant mice were treated with the SOD/catalase mimetic, EUK-8. Methods and Results: Presymptomatic heart/muscle-specific Mn-SOD-deficient mice (H/M-Sod2-/-) were treated with EUK-8 (30 mg · kg-1 · day-1) for 4 weeks, and then cardiac function and the reactive oxygen species (ROS) production in their heart mitochondria were assessed. EUK-8 treatment suppressed the progression of cardiac dysfunction and diminished ROS production and oxidative damage. Furthermore, EUK-8 treatment effectively reversed the cardiac dilatation and dysfunction observed in symptomatic H/M-Sod2-/- mice. Interestingly, EUK-8 treatment repaired a molecular defect in connexin43. Conclusions: EUK-8 treatment can prevent and cure murine DCM, so SOD/catalase mimetic treatment is proposed as a potential therapy for DCM. (Circ J 2009; 73: 2125-2134)

著者関連情報
© 2009 THE JAPANESE CIRCULATION SOCIETY
前の記事 次の記事
feedback
Top